But why would a director with 13.5m shares shoot himself in the foot this way?It just looks like woeful decision making to me.$6 - $3 x 13.5m = approx $40m worth of mistake.........
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%